Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
International Journal of Cancer|July 24, 2009
Non-toxic melanoma therapy by a novel tubulin-binding agentRitu Aneja, Seneshaw Asress, Neerupma Dhiman, et al.Carcinogenesis|June 9, 2012
A novel microtubule-modulating agent EM011 inhibits angiogenesis by repressing the HIF-1α axis and disrupting cell polarity and migrationPrasanthi Karna, Padmashree C G Rida, Ravi Chakra Turaga, et al.British Journal of Cancer|March 24, 2017
Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancerKaruna Mittal, Shashi Donthamsetty, Ramneet Kaur, et al.Journal of Ovarian Research|March 20, 2016
A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomasKaruna Mittal, Da Hoon Choi, Sergey Klimov, et al.Oncotarget|April 15, 2015
Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancersVaishali Pannu, Karuna Mittal, Guilherme Cantuaria, et al.Scientific Reports|February 16, 2018
Pharmacokinetic-pharmacodynamic correlations in the development of ginger extract as an anticancer agentRao Mukkavilli, Chunhua Yang, Reenu Singh Tanwar, et al.Oncotarget|March 20, 2015
HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patientsVaishali Pannu, Padmashree C G Rida, Angela Ogden, et al.Plos One|January 14, 2017
Distinctions in Breast Tumor Recurrence Patterns Post-Therapy among Racially Distinct PopulationsNikita Wright, Jun Xia, Guilherme Cantuaria, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 15, 2019
The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohortsMansour Alsaleem, Michael S Toss, Chitra Joseph, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2017
Preclinical Development of a Nontoxic Oral Formulation of Monoethanolamine, a Lipid Precursor, for Prostate Cancer TreatmentRoopali Saxena, Chunhua Yang, Mukkavilli Rao, et al.Pageof 4